Anil Shrivastava
Anil Shrivastava is a seasoned professional with a robust educational background and extensive experience in the finance and healthcare sectors.
He holds an MBA in Business Administration and Management from Harvard Business School and an A.B. in Economics, Magna Cum Laude, from Harvard University.
Currently, Anil serves as the Managing Partner at 325 Capital, where he demonstrates his leadership and strategic acumen.
Previously, he served as an Adjunct Professor of Finance at Brandeis International Business School, further showcasing his expertise in the field.
Anil's past roles include Chairman and Board Member at various organizations such as Vein Clinics of America, IntegraMed Fertility, and New York Hall of Science, among others.
His experience also extends to investment management, having been a Partner and Member of the Investment Committee at Sagard Capital and a Managing Director at Vestar Capital Partners.
Anil Shrivastava's tenure as Chairman, Board Member, and Managing Director in diverse companies highlights his versatile skill set and professional contributions.
With a background that merges academia, finance, and healthcare, Anil Shrivastava stands out as a multifaceted professional with a wealth of experience.